These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 20626115)

  • 1. Community opinions in the management of corneal ulcers and ophthalmic antibiotics: a survey of 4 states.
    Hsu HY; Nacke R; Song JC; Yoo SH; Alfonso EC; Israel HA
    Eye Contact Lens; 2010 Jul; 36(4):195-200. PubMed ID: 20626115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Community practice patterns for bacterial corneal ulcer evaluation and treatment.
    Park J; Lee KM; Zhou H; Rabin M; Jwo K; Burton WB; Gritz DC
    Eye Contact Lens; 2015 Jan; 41(1):12-8. PubMed ID: 25536529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential care of corneal ulcers in the community based on apparent severity.
    McLeod SD; DeBacker CM; Viana MA
    Ophthalmology; 1996 Mar; 103(3):479-84. PubMed ID: 8600426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Shifting trends in bacterial keratitis in south Florida and emerging resistance to fluoroquinolones.
    Alexandrakis G; Alfonso EC; Miller D
    Ophthalmology; 2000 Aug; 107(8):1497-502. PubMed ID: 10919897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current diagnosis and treatment of corneal ulcers.
    Benson WH; Lanier JD
    Curr Opin Ophthalmol; 1998 Aug; 9(4):45-9. PubMed ID: 10387468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Community care of corneal ulcers.
    McDonnell PJ; Nobe J; Gauderman WJ; Lee P; Aiello A; Trousdale M
    Am J Ophthalmol; 1992 Nov; 114(5):531-8. PubMed ID: 1443013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of ofloxacin vs cefazolin and tobramycin in the therapy for bacterial keratitis. Report from the Bacterial Keratitis Study Research Group.
    O'Brien TP; Maguire MG; Fink NE; Alfonso E; McDonnell P
    Arch Ophthalmol; 1995 Oct; 113(10):1257-65. PubMed ID: 7575256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of moxifloxacin 0.5% in treatment of nonperforated bacterial corneal ulcers: a randomized controlled trial.
    Sharma N; Goel M; Bansal S; Agarwal P; Titiyal JS; Upadhyaya AD; Vajpayee RB
    Ophthalmology; 2013 Jun; 120(6):1173-8. PubMed ID: 23415776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of ciprofloxacin ophthalmic solution 0.3% to fortified tobramycin-cefazolin in treating bacterial corneal ulcers. Ciprofloxacin Bacterial Keratitis Study Group.
    Hyndiuk RA; Eiferman RA; Caldwell DR; Rosenwasser GO; Santos CI; Katz HR; Badrinath SS; Reddy MK; Adenis JP; Klauss V
    Ophthalmology; 1996 Nov; 103(11):1854-62; discussion 1862-3. PubMed ID: 8942881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The utility of culturing corneal ulcers in a tertiary referral center versus a general ophthalmology clinic.
    Rodman RC; Spisak S; Sugar A; Meyer RF; Soong HK; Musch DC
    Ophthalmology; 1997 Nov; 104(11):1897-901. PubMed ID: 9373123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical antibiotics for the management of bacterial keratitis: an evidence-based review of high quality randomised controlled trials.
    McDonald EM; Ram FS; Patel DV; McGhee CN
    Br J Ophthalmol; 2014 Nov; 98(11):1470-7. PubMed ID: 24729078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of cultures in the management of ulcerative keratitis.
    Levey SB; Katz HR; Abrams DA; Hirschbein MJ; Marsh MJ
    Cornea; 1997 Jul; 16(4):383-6. PubMed ID: 9220233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased incidence of corneal perforation after topical fluoroquinolone treatment for microbial keratitis.
    Mallari PL; McCarty DJ; Daniell M; Taylor H
    Am J Ophthalmol; 2001 Jan; 131(1):131-3. PubMed ID: 11162991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of smears, cultures, and antibiotic sensitivity testing in the management of suspected infectious keratitis.
    McLeod SD; Kolahdouz-Isfahani A; Rostamian K; Flowers CW; Lee PP; McDonnell PJ
    Ophthalmology; 1996 Jan; 103(1):23-8. PubMed ID: 8628555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized clinical study for comparative evaluation of fourth-generation fluoroquinolones with the combination of fortified antibiotics in the treatment of bacterial corneal ulcers.
    Shah VM; Tandon R; Satpathy G; Nayak N; Chawla B; Agarwal T; Sharma N; Titiyal JS; Vajpayee RB
    Cornea; 2010 Jul; 29(7):751-7. PubMed ID: 20489580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluoroquinolone and fortified antibiotics for treating bacterial corneal ulcers.
    Gangopadhyay N; Daniell M; Weih L; Taylor HR
    Br J Ophthalmol; 2000 Apr; 84(4):378-84. PubMed ID: 10729294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluoroquinolones in the treatment of bacterial keratitis.
    Bower KS; Kowalski RP; Gordon YJ
    Am J Ophthalmol; 1996 Jun; 121(6):712-5. PubMed ID: 8644818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Empirical or culture-guided therapy for microbial keratitis? A plea for data.
    McDonnell PJ
    Arch Ophthalmol; 1996 Jan; 114(1):84-7. PubMed ID: 8540856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of topical fixed-combination fortified vancomycin-amikacin (VA solution) to conventional separate therapy in the treatment of bacterial corneal ulcer.
    Chiang CC; Lin JM; Chen WL; Chiu YT; Tsai YY
    Eye (Lond); 2009 Feb; 23(2):294-8. PubMed ID: 18188174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical pattern and antibiotic sensitivity of bacterial corneal ulcers in Kano, Northern Nigeria.
    Abubakar UM; Lawan A; Muhammad I
    Ann Afr Med; 2018; 17(3):151-155. PubMed ID: 30185685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.